An online search for semaglutide can lead to a licensed U.S. pharmacy, a telehealth referral service, a comparison website or an unlicensed seller. These sites can look similar even though they do very different things. Before placing an order for Ozempic or Wegovy, identify the entity that will actually dispense the medicine and confirm that its license and prescription procedure fit your state.
This is a step-by-step verification procedure rather than a ranking of stores. The goal is to assemble independent evidence: the pharmacy’s legal name, business address, active license, a functioning pharmacist contact and a legitimate prescription requirement. A professional website, low price, payment processor or attractive verification logo is not proof of a lawful dispenser.
Use this checklist before entering medical or payment information, and repeat it if a seller changes its dispensing partner. For broader shopping-channel choices start with how online semaglutide pharmacies differ; for identifying FDA-approved products use the U.S. product directory.
Look beyond the storefront brand to its terms, prescription instructions, state-specific disclosures and the name of the licensed entity that physically dispenses the medication. A telehealth clinician, marketing platform and pharmacy may be three separate companies. If the seller cannot identify the dispensing pharmacy before payment, you cannot complete meaningful license checks.
Record the legal name, address, phone number and state where the prescription would be dispensed. Compare those details with the pharmacy’s own contact information; do not assume the web domain or customer-support brand is the license holder.
Use FDA BeSafeRx guidance to reach the relevant state board of pharmacy license lookup. Search the dispensing entity by legal name or license number, inspect its status and confirm the address. Requirements for nonresident pharmacies and shipping to your home state can differ, so check whether the seller may lawfully serve your location.
A directory listing is evidence to investigate, not the end of verification. If there is no matching pharmacy, a suspended license, conflicting addresses or a mystery fulfillment partner, stop and ask the board or pharmacy for clarification before ordering.
Work through each row before accepting a storefront’s claims. The listed checks are independent actions, not a certification given by this website. A seller that passes one row can still fail others.
If an item cannot be confirmed, keep the order on hold. The related counterfeit-warning guide covers concerns about a product already received, rather than the seller-verification process.
| Claim to check | Independent evidence | Reason to pause | Practical action |
|---|---|---|---|
| Legal pharmacy name | State board register and storefront legal terms | Only an untraceable brand name is provided | Request exact dispensing entity |
| Active license | Current board record for correct entity and location | Missing, expired or mismatched status | Confirm with state board |
| Prescription requirement | Licensed clinician evaluation and valid prescription processing | “No Rx needed” checkout | Do not order |
| Pharmacist access | Reachable U.S. pharmacist contact | Only a sales agent or chatbot | Request pharmacist contact |
| Product identity | Exact brand, form, strength and packaging | Generic “semaglutide” without identified approval | Check product approval before paying |
| Fulfillment destination | Permitted state service and clear shipping policy | Unknown or overseas shipping origin | Clarify distribution and import status |
FDA-approved semaglutide products are prescription-only in the United States. A pharmacy should accept a valid prescription from an authorized clinician and confirm the requested brand, formulation and strength. A quick online questionnaire by itself does not guarantee that a licensed clinician has assessed whether treatment is appropriate.
If you need an evaluation, the online prescription guide explains the medical workflow. If you already have a prescription, ask the dispensing pharmacist what documentation is needed and whether an electronic transfer or new prescription is required.
FDA highlights the importance of a licensed pharmacist available for questions. Try a genuine product-specific question: does the pharmacy dispense the exact Ozempic tablet or Wegovy pen shown on the prescription, and how would it resolve a dispensing mismatch?
A legitimate service should be able to identify the pharmacist-contact process and its actual role in prescribing versus dispensing. An anonymous helpdesk that can only collect card numbers is not equivalent to professional pharmacy oversight.
“Semaglutide” is not a universal product identifier. Match the exact product on the prescription to its current FDA-approved name and form. Ozempic injections and tablets differ; Wegovy has tablets, standard injections and a separate HD presentation with labeling distinctions.
Use Ozempic product information and Wegovy product information to confirm identity. An Indian-approved product or a compounded preparation is not automatically an FDA-approved generic substitute.
Do not share full medical history or card details until the pharmacy and clinical parties have been identified. Read its privacy policy, total payment terms, cancellation conditions and whether referral compensation could influence how a product is presented.
A secure checkout icon, coupon, discount, site registration or claimed “FDA pharmacy approval” cannot replace a current state license. Legitimate fees may involve consultation and dispensing as separate transactions; investigate whichever entity charges each fee.
Confirm whether a licensed pharmacy offers pickup, mail service or home delivery to your state, and ask who would handle returns or a damaged shipment. Injectable pens and oral tablets have different label-based handling requirements. Delivery marketing should not be treated as proof of adequate temperature control.
For practical receipt and packaging checks, see semaglutide delivery and shipping. Do not assume a verified license establishes real-time inventory or a guaranteed arrival date.
Examples include prescription-free injectable Ozempic or Wegovy, unknown overseas dispensing, “FDA-approved compounded semaglutide,” an untraceable U.S. address, implausible cure claims or aggressive pressure to pay before receiving the dispenser’s identity.
Treat these as indicators that require further checking, not an accusation that a particular named business is counterfeit. For product-specific fraud and authenticity concerns, read counterfeit semaglutide warning signs.
Save the seller’s claimed legal name, address, product description, screenshots of its public offer and the date you checked. Do not send medical documents to an unverified entity merely to resolve the discrepancy. Contact the relevant state board or the pharmacy using independently verified contact information.
If you suspect illegal prescription-drug marketing, FDA has consumer reporting and internet-pharmacy complaint routes. If a product has already been received, ask a licensed pharmacist to assess it before use.
Once the dispensing entity and prescription requirement have been confirmed, move to the actual transaction: obtaining Ozempic or obtaining Wegovy. Those guides cover brand-specific steps; this page focuses on verification evidence rather than general checkout instructions.
A verified pharmacy may still lack a particular presentation, a plan may refuse coverage, or a prescriber may decide treatment is unsuitable. None of those outcomes changes the need for independent pharmacy checks.
This independent guide explains product and purchasing questions but is not a pharmacy, prescriber, insurer, product-authentication laboratory or real-time inventory service. Some outbound commercial links elsewhere on this website may be affiliate or sponsored referrals, and the site may receive compensation when readers use them. Such relationships are disclosed alongside the relevant outbound link; compensation does not validate a seller or guarantee a prescription. Regulatory information was checked against FDA and other named official guidance on October 18, 2026; verify current requirements before acting.
This checklist reflects FDA BeSafeRx licensing and prescription guidance reviewed on October 18, 2026. Directory status and state law can change. This website does not issue pharmacy certifications, operate a verification registry or endorse a seller merely because it appears in an advertisement.
No. A logo or claimed endorsement is not proof of state licensing. Verify the actual dispensing pharmacy through official state-board records.
Find the appropriate state board of pharmacy license database, identify the legal dispenser and confirm current licensing and relevant service permissions.
No. FDA-approved Ozempic and Wegovy products require a valid prescription from an authorized clinician.
Provider licensing and dispensing licensing are separate. Ask for the pharmacy’s legal name and verify its authority before buying.
No. Licensing indicates regulatory status, not inventory, price, insurance approval or delivery timing.
Do not assume a foreign seller may lawfully dispense an FDA-approved prescription drug to a U.S. consumer. Confirm applicable import and licensing rules first.
Not necessarily. Rankings and paid listings can be advertising. The relevant evidence is an official licensing record and a real prescription-dispensing process.
No. Payment security does not establish pharmacy licensing, authorized supply or the authenticity of the medicine.
Pause the transaction and ask the relevant state board or pharmacy using independently verified contact details to resolve the mismatch.